Assessment of Food and Drug Administration Hiring and Retention; Public Meeting; Request for Comments

摘要

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Assessment of FDA Hiring and Retention". The purpose of the public meeting is to share high-level findings from a recently completed diagnostic assessment of FDA's hiring process conducted by a qualified, independent contractor with expertise in assessing human resources operations and transformation. The purpose also is to outline a set of near-term actions FDA will or can take to improve the hiring process, provide an update on FDA's progress toward Prescription Drug User Fee Act (PDUFA) and Biosimilar User Fee Act (BsUFA) user fee hiring and retention commitments, and solicit input on actions FDA is taking and any further recommendations or priorities FDA should pursue with regard to the hiring process.